PharmAust ready to trial monepantel on humans to fight motor neurone disease
PharmAust (ASX: PAA) executive chairman and CEO Dr Roger Aston joins Small Caps to discuss the latest news in relation to its lead drug monepantel (MPL).
The biotechnology company has been focused on repurposing the drug as a treatment for cancer and neurodegenerative diseases. It has now confirmed it is ready to proceed with human trials of MPL on patients with motor neurone disease (MND).
The clinical trial will test the safety and tolerability of the drug and identify any signs that indicate it may be capable of slowing the disease.
Tablets specially designed for the trial were made to current good manufacturing practices (cGMP) and have already been shipped to Sydney and Melbourne.
The trial is being funded with support from FightMND, the largest independent funder of MND research in Australia.
PharmAust also has a medicinal chemistry contracting subsidiary based in Perth called Epichem. Earlier this week, it announced new general manager and business development manager appointments.
Articles:
https://smallcaps.com.au/pharmaust-moves-closer-trials-monepantel-patients-motor-neurone-disease/
https://smallcaps.com.au/pharmaust-appoints-new-general-manager-epichem-subsidiary/
For more information on PharmAust:
https://smallcaps.com.au/stocks/PAA/
-----------------------
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.
-----------------------
WEBSITE
https://smallcaps.com.au/
PODCAST
https://smallcaps.com.au/podcast/
SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/
NEWSLETTER
https://smallcaps.com.au/subscribe/
-
19:05
Small Caps
8 months agoPharmAust's new CEO on his journey in biotech and vision for the company
45 -
1:49
Reuters
1 year agoMusk's Neuralink says the FDA approved human trials
84510 -
54:08
ProgressPotentialAndPossibilities
1 year agoDr. Michael Hufford, PhD - Advancing Novel Therapeutic Interventions For Unmet Medical Needs
13 -
2:55
NewsUpdate
1 year agoNew treatment hailed as major breakthrough in fighting Alzheimer’s
44 -
1:44
FLCCC ALLIANCE
2 months ago $2.44 earnedEmerging Neurological Disorders - A Path to Solutions: Neurologist Dr. Suzanne Gazda Speaking at FL
1.86K -
0:18
RedChip
9 months agoReviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs
3 -
42:25
UROS751
11 months agoBig Pharma - How much power do drug companies have? | DW Documentary
31 -
59:23
ProgressPotentialAndPossibilities
1 year agoSavva Kerdemelidis - Founder & CEO - Crowd Funded Cures - Curing Patients Without Patents
12 -
2:43
Just the News
1 year agoFDA considers gene therapy to treat rare muscle disease
1.86K1 -
2:10
Reuters Innovation
2 years agoThe Argentinean scientists revolutionizing spinal muscular atrophy treatment
33